NCT05809895 2023-07-24
AdvanTIG-211
Novartis
Phase 2 Withdrawn
Clinical Trials
3 trialsNCT02538432 2019-11-04
Phase II Trial of EP4 Receptor Antagonist, AAT-007 (RQ-07; CJ-023,423) in Advanced Solid Tumors
University of Maryland, Baltimore
Phase 2 Withdrawn
NCT00005614 2012-09-25
Management of Metastatic Breast Cancer in Frail Patients
H. Lee Moffitt Cancer Center and Research Institute
Phase 2 Withdrawn